The Westaim Corporation - Webcast advisory

                           The Westaim Corporation
                  Webcast of Annual Meeting of Shareholders
                            and Investor Briefing

                            Wednesday May 2, 2007
                               10:00 a.m. EDT

    CALGARY, April 25 /CNW/ - The Westaim Corporation will hold a webcast at
10:00 a.m. EDT on Wednesday May 2, 2007 to broadcast the company's Annual
Meeting of Shareholders and Investor Briefing.
    The Westaim Corporation will be releasing its 2007 first quarter results
on Tuesday May 1, 2007.
    In addition to standard disclosure over wire services, a news release and
financial statements will be posted on the Westaim web site. To listen to the
Annual Meeting of Shareholders and Investor Briefing webcast live on the
Internet, please go to
    Ian W. Delaney, Chairman of the Board, The Westaim Corporation and Barry
M. Heck, President & Chief Executive Officer, The Westaim Corporation will
participate on the webcast.
    An audio file of the webcast will be archived and posted on the Westaim
web site.
    The Westaim Corporation's technology investments include iFire Technology
Corp., which is developing a low-cost flat panel display technology and a
74.8 per cent interest in NUCRYST Pharmaceuticals Corp. (NASDAQ:   NCST; TSX;
NCS), which develops, manufactures and commercializes medical products that
fight infection and inflammation based on its nanocrystalline silver
technology. Westaim's common shares are listed on NASDAQ under the symbol WEDX
and on The Toronto Stock Exchange under the trading symbol WED.

    %SEDAR: 00002793E

For further information:

For further information: Gillian McArdle, (416) 504-8464,

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890